In metastatic gastrointestinal solid tumors with ascites, including pancreatic cancer, TIM-3 co-expresses with PD-1 on TILs, which is associated with worse clinical outcomes [139]. Here, HAVCR2 is linked to familial pancreatic carcinoma.